Nijiro Nohata

12PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDeep learningMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 09, 2024
First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048.

Nobuhiko Oridate, Shunji Takahashi, Kaoru Tanaka

|Aug 26, 2022
Genome-Wide Super-Enhancer-Based Analysis: Identification of Prognostic Genes in Oral Squamous Cell Carcinoma.

Tomoaki Saito, Shunichi Asai, Nozomi Tanaka

|Mar 25, 2022
Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma.

Shunichi Asai, Ayaka Koma, Nijiro Nohata

|Apr 03, 2021
Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target.

Shunsuke Misono, Keiko Mizuno, Takayuki Suetsugu

|Dec 09, 2020
Correction: Rigiracciolo, D.C., et al., IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. Cells 2020, 9, 1010.

Damiano Cosimo Rigiracciolo, Nijiro Nohata, Rosamaria Lappano

|Nov 12, 2020
Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.

Yoshiaki Shinden, Tadahiro Hirashima, Nijiro Nohata

Pageof 2

Frequent Collaborators

4 joint publications

Naohiko Seki

2 joint publications

Toyoyuki Hanazawa

2 joint publications

Katsuhiro Uzawa

2 joint publications

Yasutaka Yamada